Tianyao Pharmaceuticals adjusts acquisition plan for Kingyork Amino Acid
Summary: Tianyao Pharmaceuticals announced its adjusted plan to acquire Kingyork Amino Acid for USD173.71 million (RMB1.16 billion). Tianyao Pharmaceuticals expects this merger to help it transition into being an API + preparation oriented producer o...
Amino Acids China E-News 201610